← All indications
Glaucoma, Open-Angle
Glaucoma in which the angle of the anterior chamber is open and the trabecular meshwork does not encroach on the base of the iris.
Subtype terms (1)
More specific conditions that are subtypes of Glaucoma, Open-Angle in the MeSH hierarchy.
Drugs by status
Approved for this indication (24)
Phase 4 trials (19)
Phase 3 trials (12)
Phase 2 trials (43)
- bamosiran
- simenepag isopropyl
- Aganepag
- al-12182
- al-37807
- al-59412
- de-104
- evodenoson
- betamethasone
- gabapentin
- lx7101
- mgv354
- nebivolol
- opa-6566
- ot-730
- phentolamine mesylate
- potassium chloride
- roscovitine
- verosudil
- sea water
- cyclosporine
- ats907
- akb-9778
- syl040012
- sodium acetate
- l-epigallocatechin
- zinc dichloride
- yinhsing
- pregabalin
- taprenepag
- +13 more
Phase 1 trials (14)
Organizations
Organization Involved with Phase 4 Indications (64)
- Pfizer
- Novartis
- Bp Consulting, Inc
- Santen Inc.
- FinnMedi Oy
- Glaukos Corporation
- Laboratoires Thea
- Pro Top & Mediking Company Limited
- Vistakon Pharmaceuticals
- I.R.C.C.S. Fondazione Santa Lucia
- Dr. Anton Hommer
- DBYAN Medicine Professional Corporation
- University of Pittsburgh
- Katholieke Universiteit Leuven
- National University of Malaysia
- Northwestern Ophthalmic Institute S.C.
- Ophthalmic Consultants Centres, Canada
- Tulane University
- Thomas Jefferson University
- University of Michigan
- University of Rochester
- University of Tampere
- University of Toronto
- University of Bern
- West Virginia University
- Wroclaw Medical University
- Yonsei University
- Laval University
- University of California, Los Angeles
- University of California, San Diego
- +34 more
Organization Involved with Phase 3 Indications (31)
- Actavis
- Adapt Produtos Oftalmológicos Ltda.
- Perrigo
- Alfred E. Tiefenbacher (GmbH & Co. KG)
- Laboratorios Sophia S.A de C.V.
- NicOx
- Ocular Therapeutix, Inc.
- Sun Pharmaceuticals
- Chong Kun Dang Pharmaceutical
- Nephron Pharmaceuticals Corporation
- Taejoon Pharm Co., Ltd.
- National Eye Institute (NEI)
- Semmelweis University
- Seoul National University
- Universidad Complutense de Madrid
- University of Oulu
- University of Tartu
- Xiamen University
- University of Vienna
- Moscow State University
- Inotek
- Medical University of Vienna
- Lee's Pharmaceutical
- SPARC
- EMS S/A
- University Mulitiprofile Hospital for Active Treatment Sv.Georgi, Bulgaria
- P. Stradina Clinical University Hospital, Latvia
- Charles University
- Johannes Gutenburg University
- Yeshiva University
- +1 more
Organization Involved with Phase 2 Indications (42)
- Novelion Therapeutics
- Acucela Inc.
- Roche
- Alleanza Pharmaceuticals, Inc.
- Aerpio Therapeutics
- American Society Of Thermalism And Climatology Inc
- Lexicon Pharmaceuticals
- Mati Therapeutics Inc.
- Othera Pharmaceuticals
- Peregrine Ophthalmic
- Altheos, Inc.
- Amakem, NV
- Envisia Therapeutics
- Otsuka
- PharmaMar
- BioLight
- World Health Organization
- Bascom Palmer Eye Institute
- Glaucoma Associates of New York
- Duke University
- Mashhad University of Medical Sciences
- Northwestern University
- University of East Anglia
- University of Maryland
- University of Pavia
- Asociación para Evitar la Ceguera en México
- University of California, Davis
- University of California, San Francisco
- University of Colorado, Denver
- ForSight Vision 5
- +12 more
Organization Involved with Phase 1 Indications (16)
- Shire
- Genentech
- Sanofi
- Eye Therapies, LLC
- Isarna Therapeutics GmbH
- Cairo University
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Stanford University
- The New York Eye & Ear Infirmary
- University of Kentucky
- University of Melbourne
- University of Miami
- Annexon
- University of Lubeck
- PolyActiva
- University of the Incarnate Word
Organization Involved with Other Experimental Indications (18)
- Aeon Astron Europe B.V.
- Aurolab
- Shanghai Jinshan Hospital
- Advanced Glaucoma Specialists
- University of London
- Harvard University
- Hermann Eye Center
- Queen's University, Belfast
- Columbia University
- Fudan University
- Tel Aviv University
- University of Cologne
- University of Texas at Houston
- Aravind Eye Hospital
- Rocky Mountain Lions Eye Institute
- Glaucoma Research Society of Canada
- University of Picardie Jules Verne
- Centre for Eye Research Ireland